EichorEICHOR
Study identifier: NCT06884631 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure

Condition: Heart Failure  ·  Sponsor: Centro Cardiologico Monzino

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

Heart failure is a complex condition involving multiple organs beyond the cardiovascular system, all influencing disease progression and prognosis. Accurate risk assessment requires considering multiple variables, as no single parameter alone provides a complete prognostic picture. This has led to the development of prognostic models combining clinical and laboratory parameters. Some of these models incorporate cardiopulmonary exercise testing (CPET), which provides key prognostic indicators. Since the 1990s, CPET has been recommended in heart failure management guidelines due to its strong prognostic value when combined with clinical data. However, existing risk models often exclude important predictors such as ventilatory parameters from CPET (VE/VCO₂), renal function, and hemoglobin levels. To address this gap, in 2012 the investigators developed the MECKI (Metabolic Exercise test data combined with Cardiac and Kidney Indexes) score, integrating oxygen consumption, ventilatory efficiency, and easily accessible biochemical and echocardiographic parameters. Unlike previous models requiring extensive data collection, MECKI is based on only six variables, making it practical and effective. Recent studies suggest the need to update the cutoff values and parameters used for risk stratification, as new therapies and treatment strategies may significantly alter prognostic accuracy in different patient populations. This study aims to expand and refine the MECKI score by updatin…

This description comes directly from the study's public registry record.

Talk to the study team

Piergiuseppe Agostoni, Professor  ·  +390258002010  ·  piergiuseppe.agostoni@ccfm.it

Elisabetta Salvioni, PhD  ·  +390258002010  ·  elisabetta.salvioni@ccfm.it

Always discuss trial participation with your own doctor first.

Locations (26)

Centro Cardiologico MonzinoMilan, Italy, ItalyRecruiting
Ospedali Riuniti di AnconaAncona, ItalyRecruiting
Istituti Clinici Scientifici Maugeri BariBari, ItalyRecruiting
Ospedale papa Giovanni XXIIIBergamo, ItalyRecruiting
Spedali Civili BresciaBrescia, ItalyNot Yet Recruiting
Spedali CiviliBrescia, ItalyRecruiting
Università di FoggiaFoggia, ItalyRecruiting
I.R.C.C.S. Ospedale San RaffaeleMilan, ItalyRecruiting
IRCCS Istituto Auxologico ItalianoMilan, ItalyRecruiting
IRCCS Multimedica- Ospedale San GiuseppeMilan, ItalyRecruiting
Istituti Clinici Scientifici Maugeri MilanoMilan, ItalyNot Yet Recruiting
Ospedale Cà Granda- A.O. NiguardaMilan, ItalyNot Yet Recruiting

+ 14 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →